Among all cancer types, high-grade MPNST, a group of aggressive soft tissue sarcomas with no effective therapies, has the highest prevalence of complete loss of PRC2 function through biallelic inactivation of the PRC2 core components EED or SUZ12 (2, 3, 13–15). Here, SUZ12 is linked to malignant peripheral nerve sheath tumor.